Polymer therapeutics designed for a combination therapy of hormone-dependent cancer

Angew Chem Int Ed Engl. 2005 Jun 27;44(26):4061-6. doi: 10.1002/anie.200462960.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminoglutethimide / analogs & derivatives
  • Aminoglutethimide / chemistry
  • Aminoglutethimide / pharmacology
  • Antibiotics, Antineoplastic / chemistry
  • Antibiotics, Antineoplastic / pharmacology
  • Breast Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Doxorubicin / analogs & derivatives
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology
  • Drug Design*
  • Drug Therapy, Combination*
  • Female
  • Humans
  • Inhibitory Concentration 50
  • Methacrylates / chemistry
  • Methacrylates / pharmacology
  • Molecular Structure
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Polymers / chemistry*
  • Polymers / pharmacology*

Substances

  • Antibiotics, Antineoplastic
  • HPMA copolymer-Dox-AGM
  • Methacrylates
  • Polymers
  • Aminoglutethimide
  • Doxorubicin
  • hydroxypropyl methacrylate